Alzheimer's disease is one of the world’s most prevalent brain disorders, being extremely difficult to treat. Alzheimer's ...

In a major breakthrough for Alzheimer’s diagnosis and treatment, scientists from Washington University School of Medicine in ...

With nearly 55 million people worldwide currently living with dementia—and Alzheimer’s accounting for 60–70% of those ...

Insoluble tau aggregates, particularly neurofibrillary tangles, play a crucial role in the pathology of Alzheimer’s disease. These aggregates correlate closely with the clinical symptoms of the ...

For decades, the gold standard for diagnosing Alzheimer's disease revolved around examining the brain post-mortem for tau and amyloid protein tangles—hallmarks of the condition. While these tangles ...

A recent study revealed that an experimental blood test for Alzheimer’s disease not only can help in accurate diagnosis but ...

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily ...

“This blood test clearly identifies Alzheimer’s tau tangles, which is our best biomarker measure of Alzheimer’s symptoms and ...

Researchers have developed a blood test based on a protein biomarker for tau tangles that can help diagnose Alzheimer’s ...

ShareA new study by researchers in the United States, has found that certain stages of sleep – deep sleep and dream sleep – ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.